Mitochondrial Dysfunction

R&D

Partner Content

4th Mitochondrial Dysfunction Drug Development Summit

Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success

Events

Copy of Bella Mitochondria-Targeted Drug Development - LinkedIn (2)

Partner Content

2nd Mitochondria-Targeted Drug Development Summit

Therapies for mitochondrial dysfunction

R&D

Allogeneic cell therapy isn’t dead, with Brian Culley

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Mitochondrial Dysfunction

Editor's Picks